IRIS
DAVI', Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.918
EU - Europa 7.808
AS - Asia 3.817
Continente sconosciuto - Info sul continente non disponibili 30
SA - Sud America 5
OC - Oceania 4
AF - Africa 3
Totale 19.585
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.893
CN - Cina 1.868
UA - Ucraina 1.850
IE - Irlanda 1.542
TR - Turchia 1.389
SE - Svezia 960
GB - Regno Unito 809
IT - Italia 728
FR - Francia 607
DE - Germania 563
FI - Finlandia 348
RU - Federazione Russa 292
IN - India 281
SG - Singapore 238
CZ - Repubblica Ceca 34
EU - Europa 26
CA - Canada 19
PL - Polonia 17
BE - Belgio 15
AT - Austria 13
IL - Israele 12
IR - Iran 12
NL - Olanda 8
VN - Vietnam 6
RO - Romania 5
A2 - ???statistics.table.value.countryCode.A2??? 4
MX - Messico 4
RS - Serbia 3
AU - Australia 2
BR - Brasile 2
CL - Cile 2
ES - Italia 2
GR - Grecia 2
HK - Hong Kong 2
JP - Giappone 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
TW - Taiwan 2
BG - Bulgaria 1
CR - Costa Rica 1
EE - Estonia 1
HU - Ungheria 1
KR - Corea 1
LI - Liechtenstein 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VE - Venezuela 1
Totale 19.585
Salva come PNG Salva come JPEG
Città #
Jacksonville 2.153
Dublin 1.532
Chandler 1.452
Princeton 744
Izmir 730
Southend 656
Nanjing 603
Wilmington 383
Cambridge 340
Ashburn 308
Dearborn 298
Beijing 297
Altamura 295
Nanchang 224
Ann Arbor 164
Singapore 139
Chieti 124
Boardman 110
Hebei 103
Shenyang 102
Woodbridge 101
Tianjin 91
Kunming 87
New York 71
Jiaxing 69
Washington 69
Grevenbroich 67
Moscow 64
Norwalk 56
Changsha 52
Hangzhou 35
Augusta 31
Orange 31
Brno 28
Jinan 28
Changchun 27
Lanzhou 26
Los Angeles 26
San Mateo 25
Ningbo 22
Houston 20
Falls Church 19
Seattle 19
Leawood 18
Brussels 15
Rome 15
Toronto 15
Helsinki 14
Pescara 13
Zhengzhou 12
Haikou 10
Hefei 10
Munich 10
Shanghai 10
Auburn Hills 9
Pune 9
Cedar Knolls 8
Tappahannock 8
Andover 7
Fuzhou 7
Guangzhou 7
Meylan 7
Bologna 6
Caserta 6
Dong Ket 6
Edinburgh 6
Simi Valley 6
Walnut 6
Düsseldorf 5
Milan 5
Mountain View 5
Perugia 5
Saint-prix 5
Taizhou 5
Catania 4
Chongqing 4
Kraków 4
Lanciano 4
Palermo 4
Radomsko 4
Secaucus 4
Taiyuan 4
Torino 4
Anzola Dell'emilia 3
Ardabil 3
Bassano Del Grappa 3
Belgrade 3
Hanover 3
Kocaeli 3
L'aquila 3
London 3
Mexico City 3
Monmouth Junction 3
Montegranaro 3
Montréal 3
Paris 3
Redmond 3
Rio Saliceto 3
Warsaw 3
Wuhan 3
Totale 12.178
Salva come PNG Salva come JPEG
Nome #
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 118
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 114
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 108
Pentraxin 3 and platelet activation in obese patients after gastric banding 107
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 106
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 105
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 102
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 101
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 100
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 100
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 98
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 96
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 95
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 94
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 92
In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients. 91
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 90
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 89
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 89
Platelet activation in obesity and metabolic syndrome. 87
Platelets and Diabetes 87
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 87
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 86
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 86
Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards 86
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 85
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 84
Determinants of platelet activation in hypertensives with microalbuminuria. 84
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 84
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 83
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 83
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 83
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 82
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 82
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 82
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications 82
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 81
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 81
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 81
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 80
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 80
Platelets and diabetes mellitus 80
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 80
A comparison of five maintenance therapies for reflux esophagitis 79
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. 78
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 78
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 78
Soluble forms of RAGE in internal medicine. 78
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 78
Coagulation and infective endocarditis: sooner or later 77
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 76
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 76
Atherothrombotic disease and the metabolic syndrome. 76
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 76
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 76
Use of non-steroidal anti-inflammatory drugs and analgesics in a cohort of hospitalized elderly patients: Results from the REPOSI study 76
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 76
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 75
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 75
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 75
Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis 75
Antipsychotic prescription and mortality in hospitalized older persons 75
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 74
Increased soluble CD40L levels in cystic fibrosis 74
Leptin increase is associated with markers of the hemostatic system in obese healthy women 74
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 74
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 74
Diabetes mellitus and thrombosis 74
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 72
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 72
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 72
What do we know about obesity? 72
Soluble RAGE in type 2 diabetes: association with oxidative stress. 71
Homocysteine modulates the CD40/CD40L system 71
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 71
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus 71
The left atrial appendage: from embryology to prevention of thromboembolism 71
Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach 71
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 71
Aterosclerosi ed aterosclerosi accelerata: ruolo e meccanismi dell’immunoflogosi. 70
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 70
Increased levels of soluble P-selectin in hypercholesterolemic patients 69
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 69
Thromboxane-Dependent Platelet Activation After Gastric Banding for Obesity. 69
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 69
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 69
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 69
Endothelial dysfunction and oxidative stress in arterial hypertension. 68
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 68
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 68
Nutraceuticals in diabetes and metabolic syndrome. 68
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 68
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 68
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 68
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 68
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 68
Short term vitamin E treatment normalizes LDL oxidative susceptibility in diabetic subjects 67
CD40 ligand and MCP-1 levels as predictors of cardiovascular events in lacunar and non-lacunar strokes. 67
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 67
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 66
Totale 8.006
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.395
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.691 1.529 343 53 107 398 224 532 470 117 428 466 24
2020/20212.055 391 12 386 11 120 487 24 20 157 326 39 82
2021/20221.396 23 29 11 218 104 20 22 121 121 53 216 458
2022/20234.430 432 654 236 425 385 931 302 299 529 45 99 93
2023/20241.973 141 79 138 51 121 642 508 72 18 33 14 156
2024/2025412 412 0 0 0 0 0 0 0 0 0 0 0
Totale 20.676